Cell Therapy News Volume 9.01 | Jan 14 2008

    0
    32
    Cell Therapy News 9.01, January 14, 2008
         In this issue: Science | Policy | Business | NIH | CBER | Regulatory
    Cell Therapy News on Facebook  Cell Therapy News on Twitter

    Top Stories

    Advanced Cell Technology Announces Creation of Human Embryonic Stem Cell Lines Without the Destruction of Embryos: Advanced Cell Technology, Inc. together with colleagues announced today the development of five human embryonic stem cell (hESC) lines without the destruction of embryos.
    Article

    Science

    Personalized Medicine through Genomic Analysis and Molecular Diagnostics
    March 31, 2008
    Boston, Massachusetts

    Enter “CONNEXON” at checkout and receive 10% off registration.
    Click here to register today.

    Fluorescent Chinese Pig Passes on Trait to Offspring
    A pig genetically modified in China to make it glow has given birth to fluorescent piglets, proving such changes can be inherited.
    Article

    Stem Cell Technique Wins U.S. Funding, Fuels Debate
    The National Institutes of Health began accepting grant applications Jan. 5 from scientists studying an advance reported in November.
    Article

    New Insight Into Factors That Drive Muscle-building Stem Cells
    There is a new explanation for how stem cells known as satellite cells contribute to building muscles up in response to exercise.
    Article

    Protein in Human Hair Shows Promise for Regenerating Nerves
    A protein found in human hair shows promise for promoting the regeneration of nerve tissue and could lead to a new treatment option when nerves are cut or crushed from trauma.
    Article

    Researchers Use Magnetism to Target Cells to Animal Arteries
    Scientists have used magnetic fields and tiny iron-bearing particles to drive healthy cells to targeted sites in blood vessels.
    Article

    Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
    Pluristem Therapeutics Inc. has announced that it has identified a second clinical indication for its proprietary PLX cells and the expansion of its pipeline of PLX products. Pluristem’s PLX-PAD is expected to begin clinical trials in the second half of 2008 in Europe for the treatment of limb ischemia associated with peripheral artery disease (PAD).
    Article

    Gene Therapy Gets Injured Mice Moving Again
    A combination of gene therapy and tissue grafts could offer an improved way to repair ruptured tendons and ligaments, including common sports injuries such as season-ending knee and shoulder problems, according to a new study in mice.
    Article

    Sangamo BioSciences Initiates Phase 2 Clinical Trial of ZFP Therapeutic in Stem Cell Mobilization
    Sangamo BioSciences, Inc. has announced the initiation of a randomized, single-blind, placebo-controlled, multi-center Phase 2 clinical trial in subjects with mild to moderate diabetic neuropathy.
    Article

    A Dog’s Stem Cell Life
    In the race to perfect “regenerative medicine,” stem cell therapy for animals is ahead of treatment for humans because it is not so strictly regulated. It’s not experimental – it’s here.
    Article

    Japan Researcher Proposes Stem Cell Bank
    Creating a bank to store a new type of stem cell produced from donors’ ordinary skin cells could help reduce time and money for treating patients with regenerative medicine in the future.
    Article

    China Offers Unproven Medical Treatments
    Western doctors warn that patients are serving as guinea pigs in a country that isn’t doing the rigorous lab and human tests that are needed to prove a treatment is safe and effective.
    Article

    China Parents to Sue Over “Tainted” Umbilical Blood
    Scores of Shanghai parents are to sue a biotech firm suspected of concealing the fact that their children’s umbilical cord blood, believed to be a likely cure for future blood diseases, was tainted.
    Article

    ABSTRACTS, REVIEWS AND SPECIAL REPORTS

    Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats
    The researchers show that human embryonic stem cell-derived dopaminergic neurons survived transplantation to the neurotoxin 6-hydroxydopamine-lesioned rat striatum and, in combination with the cells newly differentiated from their progenitors, contributed to locomotive function recovery at 5 months.
    Abstract

    JOB OPPORTUNITIES

    Cell Therapy Business Development Leader
    Portland, OR (Invitrogen)
    Link

    Scientist
    Irvine, CA (Global Biopharmaceutical Company)
    Link

    Biomedical Equipment Technician
    Los Angeles, CA (Cedars-Sinai Medical Center)
    Link

    Quality Manager
    Singapore (Singapore Cord Blood Bank)
    Link

    Policy

    Women Donate Eggs for Cheaper IVF
    A UK fertility centre has started a scheme offering half-price IVF treatment for women who donate their eggs to research.
    Article

    United Kingdom MP’s ‘Life-saving’ Cord Blood Bid
    An MP is to launch a bid to get doctors to offer parents the option of storing their baby’s umbilical cord blood.
    Article

    New York Gives $14.5M for Stem Cell Research
    State officials announced $14.5 million in grants to medical institutions for stem-cell research, the first allocation of a planned $600 million in aid over 10 years to expand the research in New York.
    Article

    Industry and Academia Team Up
    For the first time in its three-year existence, the state taxpayer-funded stem cell institute is offering grant money to biotechnology companies.
    Article

    Strong Support For Embryonic Stem Cell Research Declines, Overall Support Remains Stable, Poll Finds
    Strong support for human embryonic stem cell research has declined nationwide from 27% in 2005 to 21% in 2007, but overall support has remained stable at about 54%, according to a survey released late last month by Virginia Commonwealth University.
    Article

    Business

    BrainStorm Cell Therapeutics and Rutgers University Join Forces to Identify a Cure for Spinal Cord Injuries via Stem Cell Research
    BrainStorm Cell Therapeutics Inc. is pleased to announce that the Company has expanded its collaboration with Rutgers University in an effort to cure spinal cord injuries through BrainStorm’s cutting-edge adult stem cell research.
    Article

    BioTime Licenses Human Embryonic Stem Cell Technology from the Wisconsin Alumni Research Foundation
    BioTime, Inc. announced it has signed a licensing agreement with the Wisconsin Alumni Research Foundation to 173 patents and patent applications filed internationally relating to human embryonic stem cell technology created by James Thomson at the University of Wisconsin-Madison.
    Article

    The University of Massachusetts Medical School and the Carnegie Institution of Washington Grant Key RNAi Rights to Oxford Biomedica
    The University of Massachusetts Medical School and the Carnegie Institution of Washington have announced that they have entered into licensing agreements with Oxford BioMedica that grants the company rights to key RNA interference patent rights.
    Article

    CryoLife, Trophic Solutions Sign Licensing Deal
    CryoLife Inc. has inked a deal with a Wisconsin company to create and market products that aid the cold storage and preservation of internal organs before they are transplanted.
    Article

    Invitrogen Announces Acquisition of CellzDirect
    Invitrogen Corporation has announced it has entered into a definitive agreement to purchase privately-held CellzDirect, Inc., based in Research Triangle Park, North Carolina, in a cash transaction for approximately $57 million.
    Article

    Southeast Baptist Joins Network of Hospitals Collecting Umbilical Cord Blood
    The Texas Cord Blood Bank has formed a new partnership with a San Antonio area hospital to create a third supply of blood from the umbilical cords of newborns.
    Article

    Lonza Offers New Immune Cell Type for Immunology Research
    Lonza Group AG said it is offering a new cell type called Poietics Human Natural Killer Cells to its existing offering of immune cell.
    Article

    Osiris Therapeutics to Receive Milestone Payment from JCR Pharmaceuticals
    The milestone payment was triggered when JCR Pharmaceuticals filed a Clinical Trial Notice to the Pharmaceuticals and Medical Devices Agency in Japan to initiate a clinical trial in patients with Graft vs. Host Disease.
    Article

    Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
    Osiris Therapeutics, Inc. has announced it has reclaimed sole worldwide rights to cardiovascular indications for Prochymal and terminated its development and commercialization agreement with Boston Scientific Corporation in order to provide Osiris with the flexibility to enter more strategically beneficial relationships.
    Article

    Advanced Cell Technology Awarded Grant from the NIH
    Advanced Cell Technology, Inc. has announced that the National Institute of General Medical Sciences at the National Institutes of Health has awarded the company an SBIR Phase 1 Small Business Grant.
    Article

    Investment Banker Gives Stanford $20 Million for Stem Cell Work
    John Scully, an investment banker at a Mill Valley firm, is giving $20 million to Stanford University for stem cell research.
    Article

    New Research Institute to Open
    An Oregon-based research institute plans to open a 130,000-square-foot campus in Florida, adding to the growing biotech cluster forming in the region.
    Article

    NIH

    Notice Regarding the Applicability of the Federal Information Security Management Act to NIH Grantees (NOT-OD-08-032)
    Link

    Revised Policy on Enhancing Public Access to Archived Publications Resulting from NIH-Funded Research (NOT-OD-08-033)
    Link

    Application of Emerging Technologies for Cancer Research (R21) (RFA-CA-08-007)
    Link

     

    Application of Emerging Technologies for Cancer Research (R33) (RFA-CA-08-008)
    Link

    Expansion of the National Mesothelioma Virtual Registry and Tissue Bank (U24) (RFA-OH-08-002)
    Link

    CBER

    Approved Biological NDA and ANDA Applications – Update
    Link

    Licensed Products and Establishments List – Update
    Link

    All new CBER information can be reached from the What’s New page at What’s New Page

    Regulatory

    FOOD AND DRUG ADMINISTRATION (United States)

    Guidance for Industry and Food and Drug Administration Staff; The Review and Inspection of Premarket Approval Applications Under the Bioresearch Monitoring Program; Availability
    Link

    Guidance for Industry and Food and Drug Administration Staff; The Review and Inspection of Premarket Approval Application Manufacturing Information and Operations; Availability
    Link

    Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use; Extension of Comment Period
    Link

    ISCT

    14th ISCT Annual Meeting

    May 17-20, 2008
    Downtown Miami, Florida

    Abstract Submission and Early Registration Deadline: January 31, 2008

    Full details at: http://www.celltherapysociety.org


     Learn more about Cell Therapy News:  Archives  |  Events  |  Update Profile  |  Contact Us